Author/Authors :
Kourosh, Beroukhim University of California, Los Angeles - David Geffen School of Medicine at UCLA, USA , Kourosh, Beroukhim University of California, San Francisco - Department of Dermatology, USA , Danesh, Melissa University of California - Department of Dermatology, USA , Nguyen, Catherine University of California - Department of Dermatology, USA , Koo, John University of California - Department of Dermatology, USA , Leon, Argentina University of California - Department of Dermatology, USA
Abstract :
Psoriasis is a chronic immune disorder that affects 2–3% of the US population. Ustekinumab, a monoclonal antibody against IL-23/12, has shown great efficacy in treating psoriasis. Here we present a rare finding of a patient with plaque-type psoriasis who was diagnosed with congestive heart failure after initiating treatment with ustekinumab. The patient experienced full recovery of cardiac function upon discontinuation of ustekinumab.
Keywords :
Psoriasis , Ustekinumab , Congestive heart failure , Adverse drug events
